Talaria Therapeutics Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Talaria Therapeutics General Information
Description
Developer of novel antiviral therapeutics intended to treat tropical fevers caused by respiratory viruses. The company adopts a de-risked approach using well-established antiviral development strategies to design varied antiviral drug bases.
Contact Information
Corporate Office
- 1 Tower Brige,100 Front Street
- Suite 1350
- West Conshohocken, PA 19428
- United States
Corporate Office
- 1 Tower Brige,100 Front Street
- Suite 1350
- West Conshohocken, PA 19428
- United States
Talaria Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Talaria Therapeutics FAQs
-
When was Talaria Therapeutics founded?
Talaria Therapeutics was founded in 1998.
-
Where is Talaria Therapeutics headquartered?
Talaria Therapeutics is headquartered in West Conshohocken, PA.
-
What industry is Talaria Therapeutics in?
Talaria Therapeutics’s primary industry is Drug Discovery.
-
Is Talaria Therapeutics a private or public company?
Talaria Therapeutics is a Private company.
-
What is the current valuation of Talaria Therapeutics?
The current valuation of Talaria Therapeutics is .
-
What is Talaria Therapeutics’s current revenue?
The current revenue for Talaria Therapeutics is .
-
When was Talaria Therapeutics acquired?
Talaria Therapeutics was acquired on 05-Oct-2000.
-
Who acquired Talaria Therapeutics?
Talaria Therapeutics was acquired by Esperion Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
